Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psilocybin
Biotech
Psyence walks away from acquisition of fellow psilocybin biotech
Psyence has walked away from its planned acquisition of Clairvoyant after completing the due diligence process.
James Waldron
Oct 7, 2024 5:16am
Psyence acquires fellow psilocybin biotech Clairvoyant
Sep 6, 2024 9:25am
Compass tracks PTSD improvements in midphase psilocybin trial
May 8, 2024 8:07am
Reunion nets $103M, one of the largest for a psychedelic biotech
May 2, 2024 6:30am
Compass, Hackensack Meridian ink research deal for psilocybin
Jan 17, 2024 10:53am
Compass shows safety in first psilocybin trial for PTSD
Dec 20, 2023 7:26am
